PP
LLY icon

Pegasus Partners’s Eli Lilly LLY Stock Holding History

Pegasus Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.34M Buy
1,516
+113
+8% +$102K 0.13% 52
2024
Q2 		$1.27M Buy
1,403
+204
+17% +$163K 0.13% 56
2024
Q1 		$933K Buy
1,199
+11
+0.9% +$7.83K 0.1% 66
2023
Q4 		$693K Sell
1,188
-56
-5% -$32.7K 0.08% 77
2023
Q3 		$668K Buy
1,244
+11
+0.9% +$5.67K 0.09% 73
2023
Q2 		$578K Sell
1,233
-88
-7% -$36.9K 0.09% 81
2023
Q1 		$454K Buy
1,321
+88
+7% +$29.7K 0.07% 87
2022
Q4 		$451K Hold
1,233
– – 0.07% 84
2022
Q3 		$399K Sell
1,233
-20
-2% -$6.34K 0.08% 86
2022
Q2 		$406K Buy
1,253
+20
+2% +$6K 0.08% 86
2022
Q1 		$353K Sell
1,233
-177
-13% -$45.6K 0.06% 88
2021
Q4 		$389K Buy
+1,410
New +$357K 0.07% 98
2018
Q1 		– Sell
-14,174
Closed -$1.2M – 155
2017
Q4 		$1.2M Sell
14,174
-5,840
-29% -$497K 0.25% 114
2017
Q3 		$1.71M Sell
20,014
-1,613
-7% -$132K 0.39% 78
2017
Q2 		$1.78M Sell
21,627
-359
-2% -$29.3K 0.47% 76
2017
Q1 		$1.85M Buy
21,986
+13,012
+145% +$1.04M 0.76% 37
2016
Q4 		$660K Sell
8,974
-7,191
-44% -$536K 0.29% 86
2016
Q3 		$1.3M Buy
16,165
+485
+3% +$38.8K 0.61% 48
2016
Q2 		$1.24M Sell
15,680
-395
-2% -$29.7K 0.64% 47
2016
Q1 		$1.16M Sell
16,075
-6,380
-28% -$483K 0.63% 47
2015
Q4 		$1.89M Buy
+22,455
New +$1.86M 0.95% 34

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pegasus Partners's LLY Position: Q3 2024 in Review

Pegasus Partners increased its Eli Lilly (LLY) stake by 8.1% in Q3 2024, buying an estimated $102K and bringing the position to 1,516 shares worth $1.34M. The position accounts for 0.13% of the portfolio, ranked #52.

Pegasus Partners first reported a position in LLY in Q4 2015 and has held it in 21 quarters since. The position peaked at $1.89M in Q4 2015. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Pegasus Partners held 1,516 shares of Eli Lilly worth $1.34M as of Q3 2024.
  • Pegasus Partners bought 113 Eli Lilly shares in Q3 2024, an estimated $102K.
  • Eli Lilly made up 0.13% of Pegasus Partners's portfolio in Q3 2024, its #52 holding.
  • Pegasus Partners first reported a position in Eli Lilly in Q4 2015 and has held it in 21 quarters since.
  • Pegasus Partners's Eli Lilly position peaked at $1.89M in Q4 2015.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Pegasus Partners's 13F filing for Q3 2024, filed 1 Nov 2024.